🔴 Alphatec Holdings is trading 29.82% down in pre-market after cutting its 2026 revenue outlook

Alphatec Holdings is trading at $7.98 (-29.82%) in pre-market on October 30 after October 29 results cited weaker biologics attachment.

• Third-quarter revenue was $221 million, below expectations; stronger surgical volumes did not offset the shortfall.
• The company cut its 2026 revenue outlook to approximately $862 million from approximately $882 million.